Targeting the IL-17 Pathway in Inflammatory Disorders (Paperback, 1st ed. 2017)

This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.

General

Imprint:	Adis International
Country of origin:	Switzerland
Release date:	December 2016
First published:	2017
Authors:	Cong-Qiu Chu
Dimensions:	203 x 127 x 7mm (L x W x T)
Format:	Paperback
Pages:	102
Edition:	1st ed. 2017
ISBN-13:	978-3-319-28039-4
Categories:	Books > Medicine > Clinical & internal medicine > Dermatology Books > Medicine > Clinical & internal medicine > Rheumatology Books > Medicine > Other branches of medicine > Pharmacology > General Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN:	3-319-28039-2
Barcode:	9783319280394

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!